Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, β-lapachone

Melissa S. Bentle, Kathryn E. Reinicke, Ying Dong, Erik A. Bey, David A. Boothman

Research output: Contribution to journalArticlepeer-review

57 Scopus citations

Fingerprint

Dive into the research topics of 'Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, β-lapachone'. Together they form a unique fingerprint.

Medicine & Life Sciences